Srinivas Akkaraju - Net Worth and Insider Trading

Srinivas Akkaraju Net Worth

The estimated net worth of Srinivas Akkaraju is at least $407 Million dollars as of 2024-07-15. Srinivas Akkaraju is the Director of Chinook Therapeutics Inc and owns about 5,161,888 shares of Chinook Therapeutics Inc (KDNY) stock worth over $208 Million. Srinivas Akkaraju is the Director, 10% Owner of Mineralys Therapeutics Inc and owns about 4,519,361 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $65 Million. Srinivas Akkaraju is also the Director, 10% Owner of Scholar Rock Holding Corp and owns about 6,788,609 shares of Scholar Rock Holding Corp (SRRK) stock worth over $62 Million. Besides these, Srinivas Akkaraju also holds Principia Biopharma Inc (PRNB) , Intercept Pharmaceuticals Inc (ICPT) , Syros Pharmaceuticals Inc (SYRS) , Seagen Inc (SGEN) , aTyr Pharma Inc (ATYR) , Aravive Inc (ARAV) . Details can be seen in Srinivas Akkaraju's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Srinivas Akkaraju has not made any transactions after 2023-12-21 and currently still holds the listed stock(s).

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Srinivas Akkaraju

To

Srinivas Akkaraju Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Srinivas Akkaraju owns 21 companies in total, including Aduro Biotech Inc (ADRO) , Syros Pharmaceuticals Inc (SYRS) , and Intercept Pharmaceuticals Inc (ICPT) among others .

Click here to see the complete history of Srinivas Akkaraju’s form 4 insider trades.

Insider Ownership Summary of Srinivas Akkaraju

Ticker Comapny Transaction Date Type of Owner
ADRO Aduro Biotech Inc 2020-10-05 director
SYRS Syros Pharmaceuticals Inc 2023-12-21 director
ICPT Intercept Pharmaceuticals Inc 2021-03-12 director
LIMIT LIMIT 2020-05-05 director
LIMIT LIMIT 2019-12-02 director
LIMIT LIMIT 2018-09-18 director
LIMIT LIMIT 2015-07-08 director
LIMIT LIMIT 2015-12-17 director
LIMIT LIMIT 2015-10-06 10 percent owner
LIMIT LIMIT 2015-09-30 10 percent owner
LIMIT LIMIT 2015-01-29 10 percent owner
LIMIT LIMIT 2014-12-02 10 percent owner
LIMIT LIMIT 2014-09-11 10 percent owner
LIMIT LIMIT 2012-12-18 10 percent owner
LIMIT LIMIT 2011-07-13 10 percent owner
LIMIT LIMIT 2011-01-05 director
LIMIT LIMIT 2022-05-27 director
LIMIT LIMIT 2021-06-24 10 percent owner
LIMIT LIMIT 2020-11-18 director & 10 percent owner
LIMIT LIMIT 2023-10-16 director
LIMIT LIMIT 2023-02-14 director & 10 percent owner

Srinivas Akkaraju Latest Holdings Summary

Srinivas Akkaraju currently owns a total of 9 stocks. Among these stocks, Srinivas Akkaraju owns 5,161,888 shares of Chinook Therapeutics Inc (KDNY) as of May 27, 2022, with a value of $208 Million and a weighting of 51.26%. Srinivas Akkaraju owns 4,519,361 shares of Mineralys Therapeutics Inc (MLYS) as of February 14, 2023, with a value of $65 Million and a weighting of 16.06%. Srinivas Akkaraju also owns 6,788,609 shares of Scholar Rock Holding Corp (SRRK) as of October 16, 2023, with a value of $62 Million and a weighting of 15.19%. The other 6 stocks Principia Biopharma Inc (PRNB) , Intercept Pharmaceuticals Inc (ICPT) , Syros Pharmaceuticals Inc (SYRS) , Seagen Inc (SGEN) , aTyr Pharma Inc (ATYR) , Aravive Inc (ARAV) have a combined weighting of 17.5% among all his current holdings.

Latest Holdings of Srinivas Akkaraju

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KDNY Chinook Therapeutics Inc 2022-05-27 5,161,888 40.39 208,488,656
MLYS Mineralys Therapeutics Inc 2023-02-14 4,519,361 14.45 65,304,766
SRRK Scholar Rock Holding Corp 2023-10-16 6,788,609 9.10 61,776,342
PRNB Principia Biopharma Inc 2018-09-18 383,480 100.05 38,367,174
ICPT Intercept Pharmaceuticals Inc 2021-03-12 663,809 19.00 12,612,371
SYRS Syros Pharmaceuticals Inc 2023-12-21 1,789,093 6.00 10,734,558
SGEN Seagen Inc 2020-05-05 40,168 228.74 9,188,028
ATYR aTyr Pharma Inc 2015-05-12 133,296 1.74 231,935
ARAV Aravive Inc 2019-12-02 607,881 0.04 24,376

Holding Weightings of Srinivas Akkaraju


Srinivas Akkaraju Form 4 Trading Tracker

According to the SEC Form 4 filings, Srinivas Akkaraju has made a total of 3 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Chinook Therapeutics Inc is the acquisition of 570,000 shares on May 27, 2022, which cost Srinivas Akkaraju around $8 Million.

According to the SEC Form 4 filings, Srinivas Akkaraju has made a total of 1 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mineralys Therapeutics Inc is the acquisition of 937,500 shares on February 14, 2023, which cost Srinivas Akkaraju around $15 Million.

According to the SEC Form 4 filings, Srinivas Akkaraju has made a total of 1 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Scholar Rock Holding Corp is the acquisition of 2,189,781 shares on October 16, 2023, which cost Srinivas Akkaraju around $15 Million.

More details on Srinivas Akkaraju's insider transactions can be found in the Insider Trading History of Srinivas Akkaraju table.

Insider Trading History of Srinivas Akkaraju

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Srinivas Akkaraju Trading Performance

GuruFocus tracks the stock performance after each of Srinivas Akkaraju's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Srinivas Akkaraju is 15.82%. GuruFocus also compares Srinivas Akkaraju's trading performance to market benchmark return within the same time period. The performance of stocks bought by Srinivas Akkaraju within 3 months outperforms 13 times out of 24 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Srinivas Akkaraju's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Srinivas Akkaraju

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
9 out of 22 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 5.46 LIMIT LIMIT LIMIT LIMIT LIMIT

Srinivas Akkaraju Ownership Network

Ownership Network List of Srinivas Akkaraju

No Data

Ownership Network Relation of Srinivas Akkaraju

Insider Network Chart

Srinivas Akkaraju Owned Company Details

What does Aduro Biotech Inc do?

Who are the key executives at Aduro Biotech Inc?

Srinivas Akkaraju is the director of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .

Aduro Biotech Inc (ADRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aduro Biotech Inc Insider Transactions

No Available Data

Srinivas Akkaraju Mailing Address

Above is the net worth, insider trading, and ownership report for Srinivas Akkaraju. You might contact Srinivas Akkaraju via mailing address: 565 Everett Avenue, Palo Alto Ca 94301.

Discussions on Srinivas Akkaraju

No discussions yet.